πŸ‡ΊπŸ‡Έ FDA
Patent

US 8697704

Hepatitis C virus inhibitors

granted A61KA61K31/137A61K31/7056

Quick answer

US patent 8697704 (Hepatitis C virus inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Enanta Pharmaceuticals, Inc.
Grant date
Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/137, A61K31/7056, A61K38/21, A61K38/212